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Abstract: Quantum dots have emerged with great promise for biological applications as 
  fluorescent markers for immunostaining, labels for intracellular trafficking, and   photosensitizers 
for photodynamic therapy. However, upon entry into a cell, quantum dots are trapped and their 
fluorescence is quenched in endocytic vesicles such as endosomes and lysosomes. In this study, 
the photophysical properties of quantum dots were investigated in liposomes as an in vitro vesicle 
model. Entrapment of quantum dots in liposomes decreases their fluorescence lifetime and 
intensity. Generation of free radicals by liposomal quantum dots is inhibited compared to that 
of free quantum dots. Nevertheless, quantum dot fluorescence lifetime and intensity increases 
due to photolysis of liposomes during irradiation. In addition, protein adsorption on the quantum 
dot surface and the acidic environment of vesicles also lead to quenching of quantum dot fluo-
rescence, which reappears during irradiation. In conclusion, the in vitro model of phospholipid 
vesicles has demonstrated that those quantum dots that are fated to be entrapped in endocytic 
vesicles lose their fluorescence and ability to act as photosensitizers.
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Introduction
Developments in material physics and chemistry have fundamentally changed detection 
and tracking of biological systems and living organisms.1 Luminescent semiconductor 
nanocrystal quantum dots (QDs) are of particular interest to many research groups 
for their ease of chemical manipulation and crystalline structure, which enable the 
creation of complex assemblies2,3 and unique photophysical characteristics such as high 
quantum yield, high molar extinction coefficient, broad excitation spectra and narrow 
symmetric emission4 that can be tuned in accordance with particle size,5 high resistance 
to chemical and photophysical degradation, and accessibility of outer shell modifica-
tions with various biologically active molecules.6 Just like organic chromophores and 
fluorophores, QDs possess electronic structure and molecular orbitals.7 These features 
make them promising for a wide range of applications in both fundamental biological 
research such as labeling agents for cellular trafficking;8,9 membrane dynamics and 
cellular movements;10,11 single particle tracking;12,13 multicolor imaging14,15 and applied 
medical research within multimodal (magnetic and optical) imaging,16,17 particularly of 
tumors;18–20 and nanoparticle-mediated drug delivery.21,22 Besides imaging, QDs are now 
emerging as therapeutic agents alone23 or in combination with external radiation.24–26 
It has been recently shown that QDs irradiated with UV radiation,27–29 blue light,30 
or red light31 generate free radicals and singlet oxygen in aqueous solutions, cell 
cultures in vitro, and mouse skin in vivo, opening one more potential field for their International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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photodynamic application. The most likely mechanism of 
photosensitized action of QDs is photogeneration of excitons 
and electron-hole pairs (e− and h+)32 and subsequent electron 
transfer to oxygen adsorbed on the QD surface forming a 
superoxide (O2
−) free radical.33 So far, the photodynamic 
effect of QDs has been demonstrated for UV radiation by 
Clarke et al on epithelial cells28 and Chang et al on pancreatic 
cells.34 Derfus et al have demonstrated cytotoxic effects of 
CdSe QDs with photocatalytically impaired capping shell 
during UV radiation on hepatocytes.35
However, therapeutic application of QDs in a biological 
environment meets challenges in delivery to target cells and 
to specific intracellular sites. In spite of the fact that QDs are 
excellent generators of free radicals and singlet oxygen (a key 
cytotoxic molecule) in aqueous solutions,30,31 our recent work 
showed no significant photodynamic action in Du145 cells 
pretreated with red fluorescent QDs under irradiation with 
blue or red light.36 This might be due to the fact that QDs 
are trapped in endocytic vesicles such as endosomes and 
lysosomes where QD fluorescence is quenched. Obviously, 
one must rehabilitate such failure of QDs to act as photosen-
sitizers under irradiation with visible light. In this work, we 
have addressed this problem by studying the photophysical 
properties of red-fluorescent QDs in phospholipid vesicles 
and in the presence of proteins. Liposomes with encapsulated 
QDs were synthesized by a fast method of extruding hydrated 
phospholipids through a polycarbonate filter using a simple, 
convenient, low-cost two-syringe system.
Materials and methods
Preparation of phospholipid vesicles
For synthesis of liposomes, 60 mol% phosphatidylcholine 
(2.025 ⋅ 10−5 mol 1,2-distearoyl-sn-glycero-3-phospho-
  choline [DSPC], gel–liquid crystal transition temperature, 
TC = 55°C, molecular weight [MW] = 790.16; Sigma Aldrich 
Norway AS, Oslo, Norway) and 40 mol% cholesterol 
(1.345 ⋅ 10−5 mol, obtained from George T Gurr Ltd, London, 
UK) were solubilized in 2 mL of chloroform in a tightly 
closed 4 mL glass vial. The solution was well mixed with 
a vortex shaker for 3 minutes, resulting in a clear solution. 
To form a dry lipid film, the chloroform was evaporated 
by immersing the glass vial with the phospholipid solution 
in the water bath (55°C) under continuous gentle shaking. 
After about 30 minutes, when most of the chloroform had 
evaporated, the rest of it was evaporated by rotating the 
vial along with a weak argon flow above the surface of the 
phospholipid/chloroform suspension. Such argon flushing 
accelerates the evaporation of chloroform and preserves 
the lipids against oxidation. To get a good lipid film, a 
large surface layer was produced. Formation of a uniform 
transparent layer of dry lipids on the walls confirms the 
yield of a lipid film. The vial was then placed into a vacuum 
dryer (Glass Oven B-585; Büchi Labortechnik AG, Flawil, 
Switzerland) to evaporate trace amounts of the chloroform 
using a vacuum pump Büchi V-700 (Büchi Labortechnik 
AG, Flawil, Switzerland). The duration of this cycle was 
1 hour at 10 mbar pressure.
If not used the same day, the formed dry lipid film 
was stored in a freezer (−20°C) in the tightly closed vial 
filled with argon gas. Then, to produce a suspension of 
phospholipids, the lipid film was hydrated under continuous 
agitation in a 10% sucrose aqueous solution (osmolality 
∼300 mOsm/kg measured with a Fiske 210 osmometer; 
Advanced Instruments Inc, Norwood, MA,) supplemented 
with 100 nmol/L QD655 (Invitrogen Corp, Carlsbad, CA). 
The temperature (65°C) of the hydrating medium was above 
TC of the lipid. The vial with the lipid suspension was then 
maintained above TC during the whole hydration period. 
After ∼30 minutes of manual agitation, a homogenous lipid 
suspension was formed.
Avestin LiposoFast equipment (Sigma-Aldrich, St Louis, 
MO) was used for the simplified liposome extrusion. The 
method involves manual handling of a two-syringe system 
capable of producing less than a milliliter of liposome sus-
pension without involving extrusion under gas pressure. 
A polycarbonate filter with a pore size of 400 nm, similar to 
the size of endocytic vesicles, was used in the experiment. 
One of the 0.5 mL glass syringes was filled with the hydrated 
lipid suspension. It was attached to an extruder with the filter 
imbedded in it, and then the second receiving syringe was 
mounted. The whole system was immersed in the water bath 
set at 65°C. By carefully pushing one syringe at a time, the 
lipid suspension was extruded back and forth many times 
through the membrane. The temperature of the lipid suspen-
sion was maintained above TC during the whole process. An 
odd number of passages was performed to avoid contami-
nation of the liposomes with the original lipid suspension. 
To get a uniform size of the liposomes, 21 passages were 
performed. Non-encapsulated QDs and lipids were removed 
by ultrafiltration at 4000 rpm (rotor radius 14 cm, centrifuge 
model 5804 R; Eppendorf AG, Hamburg, Germany) using 
a 200 nm Vivaspin 6 filter (Vivascience AG, Hannover, 
Germany). Then, the liposomes were resuspended with the 
10% sucrose solution to bring the suspension to the original 
volume (0.5 mL). When not in use, the liposomes were stored 
in a refrigerator (4°C).International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Quantum dots used in this study
Red fluorescent commercial QDs (QD655) used in this study 
consist of a CdSe core with a ZnS shell and are coated with 
polyethylene glycol (PEG) with carboxyl-terminated groups. 
They were purchased from Invitrogen Corp as 8 µM stock 
solutions in borate buffer and further diluted in water to nec-
essary concentrations. The CdSe QDs have broad absorption 
profiles with strong intensities in the ultraviolet (UV) region 
and decreasing toward the red spectral region with their first 
exciton peak at 650 nm and are defined as QD655 due to the 
position of the fluorescence maximum at 655 nm.37
Particle size measurements
The sizes of the QD655 (Invitrogen Corp) and the liposomes 
produced in our laboratory were measured in phosphate 
buffered saline (PBS) by the dynamic light scattering (DLS) 
technique using a Nano ZS Zetasizer (Malvern Instruments 
Ltd, Malvern, UK).
Transmission electron microscopy (TeM)
The nanoparticles were imaged with a JEM-1230 transmission 
electron microscope (JEOL Ltd, Tokyo, Japan) and 11 mega-
pixel side-mounted TEM camera “Morada”   (Olympus Soft 
Imaging Solutions PTE Ltd, Munster, Germany). The QDs 
were first diluted with sucrose (330 mOsmol/kg, buffered 
with (4-[2-hydroxyethyl]-1-piperazineethanesulfonic acid 
[HEPES] 10 mM, pH 7.4) then dropped onto copper grids 
and allowed to stay for 5 minutes for the QDs to settle. Excess 
sucrose was removed, and the grid was dried prior to   imaging. 
To image the liposomes, a drop of liposomal suspension in 
sucrose was placed onto the copper grid for 5 minutes. The 
excess sucrose was then removed with lint-free drying paper. 
Uranyl acetate 2% aqueous solution was dropped just after 
the sucrose removal and allowed to stay for 30 seconds. The 
excess of uranyl acetate was then soaked up, and the grid was 
dried at room temperature for several minutes.
Fluorescence microscopy
Du145 cells were grown on 35 mm Petri dishes with bottom 
glass (thickness number 1.0) for microscopy coated with 
poly-d-lysine (MatTek Corp, Ashland, MA). For visualization 
the Du145 cells were transfected with an actin-green fluores-
cent protein (actin-GFP) gene following the manufacturer’s 
protocol (Cellular Lights Actin-GFP, Invitrogen Corp) by 
incubating the cells for 1.5 hours with baculovirus and then 
for another 1.5 hours with expression enhancer. Afterward, 
the Du145 cells were incubated for 24 hours with 10 nmol/L 
QD655. The cells were visualized with a Carl Zeiss Axiovert 
40 CFL microscope (Carl Zeiss Inc, Oberkochen, Germany) 
using a 100 × oil immersion objective (Carl Zeiss Achroplan, 
NA = 1.25). Fluorescence photographs were taken approxi-
mately every 9–11 seconds for a total of 90 seconds illumina-
tion with the microscope light filtered to give excitation at 
450–480 nm. Image capture parameters were automatically 
set by the software (Carl Zeiss Axiovision 4.6, Carl Zeiss 
Inc) for the first image in a set. Thereafter, all images in a 
sequence retained the same image capture parameters. The 
image integration time was 2818 milliseconds. Pixel intensity 
values are presented on a scale of 0–255.
Measurements of steady state 
fluorescence and decay kinetics
The fluorescence of QD655 in aqueous solutions was mea-
sured at 655 nm under excitation at 400 nm in a standard 
1 cm path length quartz cuvette with an LS50B luminescence 
spectrometer (PerkinElmer, Waltham, MA) using a standard 
cuvette holder providing 90° between excitation beam and 
emission detection.
Fluorescence of rhodamine 123 (Rh123)/dihydrorho-
damine 123 (DHR) in aqueous solutions was measured 
at 525 nm with a USB2000FL fluorescence spectrometer 
(Ocean Optics Inc, Duiven, the Netherlands) under excitation 
at 475 nm using an Ocean Optics integrated light emitting 
diode (LED) source.
Fluorescence decay kinetics were measured in a 
standard 1 cm path length quartz cuvette with an EasyLife 
V instrument (OBB Corp, Birmingham, NJ). Fluorescence 
of QDs was excited with a pulsed LED source (peak 400 nm 
with half bandwidth 20 nm, pulse half width 2 ns) and mea-
sured using a dichroic filter on the detection side (650 nm 
with 10 nm band pass). Instrument response function (IRF) 
was measured in a cuvette containing ultrapure water. 
Lifetime calculations were performed with the EasyLife V 
proprietary software (OBB Corp).
In all solutions used for fluorescence decay measure-
ments, the final concentration of QD655 was 10 nmol/L. 
Lipodots were mixed with PBS in 1:1 ratio (v/v) prior to 
the experiments. A solution of 0.1% w/v Triton X-100 was 
prepared in distilled water, and 1% w/v bovine serum albu-
min (BSA) was prepared in PBS. The suspension of empty 
liposomes (without QD655) in 40% sucrose aqueous solution 
was mixed with PBS in 1:1 ratio (v/v) prior to the addition 
of the QDs, and then 10 nmol/L QD655 was freshly added 
before each measurement. The decay curves are averages of 
three independent measurements. See supporting material 
for calculated fluorescence lifetimes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Oxygen measurements
A FOXY-21G fiber-optic probe (OceanOptics BV) connected 
to the fluorescence spectrometer (USB2000FL, Ocean Optics 
BV) was used to measure oxygen concentrations. The oxygen 
probe was calibrated against three reference points: 21% in 
the air as well as 0% and 100% in a flask flushed with pure 
argon and oxygen, respectively.
For oxygenation, samples were flushed with pure oxygen 
that saturated water with approximately 80% dissolved   oxygen 
measured at T = 23° C, Patm = 756 mmHg (100,7 kPa). After 
stopping oxygen flushing, oxygen concentration decreased 
to 70% within 15 minutes. To remove oxygen, the samples 
were flushed with argon for approximately 30 minutes. After 
flushing, the cuvette was immediately closed with its stopper. 
Argon flushing enabled the reduction of the dissolved oxy-
gen concentration in water to ∼7%. After the argon flushing 
stopped, the oxygen concentration gradually increased to 15% 
within ten minutes. In other samples, dissolved oxygen was 
removed by adding 1 mol/L sodium sulfite (Na2SO3), which 
permanently reduced oxygen concentration to 0.4% for the 
duration of the experiment.
Irradiation with light
The emission spectra of the light sources used in this study 
can be found in our earlier publication.37 A blue light illumi-
nator, made in-house, composed of four luminescence tubes 
(Philips TL 40 W/03; Philips, Amsterdam, the Netherlands) 
gives a broad emission band at 390–460 nm with a peak at 
∼420 nm. Samples were placed on the lamp, and the fluence 
rate was 11 mW/cm2 at the position of the samples. A com-
mercially available red light source (Aktilite CL128) was 
kindly provided by PhotoCure ASA (Oslo, Norway). This 
lamp has an LED array with a peak at ∼630 nm. The distance 
between the bottom of the cuvette with the sample and the 
outer surface of the LED lamp was 10 cm and the measured 
fluence rate was 80 mW/cm2 at the position of the bottom 
of the cuvette. The fluence rate of both lamps was measured 
with a Newport model 1815-C power meter (Newport Corp, 
Irvine, CA) equipped with a photodiode detector (818-SL) 
and attenuation filter (883-SL). The final concentration of 
QD655 was 10 nmol/L in PBS. The lipodots were mixed 
with PBS in 1:1 ratio (v/v).
Determination of free radical generation 
capacity
Generation of free radicals and reactive oxygen species 
(ROS) was determined by measuring the appearance of 
Rh123, which is the oxidation product of its reduced non-
fluorescent form DHR (Sigma-Aldrich). During the oxida-
tion of DHR, absorbance and fluorescence increases.38 Its 
absorption and fluorescence bands are at 490–500 nm and 
530 nm, respectively. For irradiation with the red LED 
light, 1 µM DHR with or without QD655 (10 nmol/L) was 
prepared in standard 1 cm path length acrylic cuvettes. One 
cuvette at a time was placed into a cuvette holder, which 
was connected with fibers to an Ocean Optics USB2000FL 
fluorescence spectrometer. The LED lamp was placed above 
the cuvette holder, and the red light was directed downward 
on the cuvette. The live acquisition mode of Ocean Optics 
software was activated during the irradiation, allowing it to 
record continuous oxidation kinetics.
To measure oxidation kinetics individually for each 
sample, background fluorescence, F0, of the radical scav-
enger (1 µM DHR) before irradiation and that of oxidized 
probes during irradiation, FOX(t), were measured over time, t. 
Total oxidant capacity (100% oxidized probe) was assessed 
by adding 1 mM of the radical generator 2,2′-azobis(2-
amidinopropane) dihydrochloride (AAPH) to each sample 
and then determining the FMAX fluorescence value for each 
sample:
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The profile of DHR oxidation follows saturation kinetics 
showing the suitability of DHR to determine maximal 
reactive oxygen species (ROS) capacity of solutions. At room 
temperature, DHR can be considered maximally oxidized after 
around 48 hours with AAPH added. It has been previously 
observed that an equimolar concentration of fully oxidized 
DHR gives half the fluorescence intensity compared to that of 
the pure compound Rh123.39 However, studying reasons for 
this discrepancy was outside the scope of this study.
Results and discussion
The lack of significant therapeutic effect of QDs described in 
our previous work36 can be partly explained by the quenching 
of their fluorescence upon entry to the cells (Figure 1A, left 
photo). During continuous observation of the cells under the 
microscope using its blue excitation light, red fluorescent dots 
appear with granular distribution (Figure 1A, right photo). 
Concomitantly with the increase of QD fluorescence, photo-
bleaching of actin-GFP staining was observed (Figure 1B).
A similar phenomenon of dimming and photoactivation of 
QD fluorescence in cultures in vitro was observed by Silver 
and Ou for QD655-poly-L-lysine-streptavidin in HeLa cells,40 International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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Clarke et al for QD560-dopamine in A9 cells,28 and in our 
previous studies for non-targeted QD655 in Du145 cells.31,36 
Silver and Ou40 postulated that fluorescence quenching 
could be attributed to the interaction of QDs with cellular 
molecules, particularly lysosomal enzymes. However, the 
authors notice that, if extensive QD degradation takes place 
in lysosomes, a blue-shift in QD fluorescence should be 
observed, which was not the case.40 Such photo-activation 
(photo-enhancement) of fluorescence has been observed 
in solutions of free QDs after exposure to sunlight,41 UV 
radiation,42 and blue light43 or QDs embedded in silica col-
loids under UV radiation.44 Normally, a decrease in QD 
fluorescence intensity occurs due to oxidative decay of the 
CdSe lattice in the presence of oxygen, while in nitrogen, 
photobleaching is absent.45 Dembski et al44 proposed that 
UV radiation generates excitons, which form O2
− from the 
oxygen adsorbed on the surface of QDs: when irradiation 
stops, O2
− dissociates, diminishing the oxygen passivation 
effect and thus decreasing QD fluorescence. However, irra-
diation for a longer period will lead to oxidation of the QD 
surface and desorption of SeO2 and SO4
−,44 accompanied 
by the release of Cd2+ and Zn2+.35 This will smooth the QD 
surface, leading to elimination of surface defects, increase 
of radiative recombination, reduction of particle size, and 
permanent enhancement of fluorescence.42,44 Overall, it is 
reasonable to assume that fluorescence properties of QDs and 
efficiency of radiative electron-hole recombination depend on 
the QD surface and its environment.46,47 Events responsible 
for such photo-reversible fluorescence of QDs have not yet 
been completely understood.48
Along the endosomal pathway, large multilamellar/ 
multivesicular granules (late endosomes and lysosomes) may 
be formed.49 Therefore, incorporation of QDs in a liposome 
model probably resembles the real situation QDs meet upon 
their entry into cells. To prepare model membranes, a fast, 
low cost, and convenient method was employed as described 
earlier by MacDonald et al.50 It has been shown that small uni-
lamellar vesicles (SUVs) or multilamellar vesicles (MLVs) of 
variable sizes can be produced simply by extruding hydrated 
phospholipids through a polycarbonate filter.51 Dynamic light 
scattering (DLS) measurements show that the average size of 
QD655 was ∼26 nm and that of the liposomes was ∼200 nm 
(Figure 2). This corresponds practically to the size determined 
by the electron microscopy. QD655 represents spherical to 
elongated quantum dots from 6 to 12 nm in size. Liposomes 
are a mixture of unilamellar and multilamellar vesicles of 
variable sizes, 100–400 nm. Transmission electron micro-
scope (TEM) images show that liposomal QDs (lipodots) 
contain dots indicating a QD655 inclusion within the lipo-
somes or their membranes (Figure 3). The encapsulation 
efficiency practically matches theoretical calculations: about 
four QDs expects to be distributed in a volume of a 400 nm 
liposome corresponding to the concentration 10 nmol/L 
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Figure 1 (A) Microscopy photographs of Du145 cells showing development of 
red fluorescent spots originating from QD655 with simultaneous photobleaching of   
actin-GFP during illumination with the microscope excitation light (450–480 nm). 
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QD655. Generation of free radicals by lipodots, as assayed 
using a radical scavenger DHR, was nearly inhibited com-
pared to that of the free QDs in water (Figure 4). This shows 
that, upon endosomal entrapment, QDs are destined to lose 
their ability to act as photosensitizers inside a cell.
We also considered the possibility that fluorescence 
changes could be attributed to variations in intracellular 
oxygen concentrations. However, we did not observe signifi-
cant differences in fluorescence decay kinetics of QDs in the 
presence or absence of oxygen (Figure 5). Argon bubbling 
does not remove all the oxygen from the aqueous solution. 
In the presence of sodium sulfite, which is a very effective 
oxygen scavenger, the QD fluorescence decay kinetics was 
similar to that in the aerated solution. The QDs used in this 
study possess high fluorescence stability and good capping 
layer formulation. The layer successfully prevents the QDs 
AB
C1 C2 C3
200 nm
C5
C4
100 nm 200 nm
200 nm
Figure 3 TeM images of the nanoparticles: (A) empty liposomes as unilamellar and multilamellar vesicles of variable sizes (100–400 nm); (B) spherical to elongated QD655 
from 6 to 12 nm in size; (C1) common view of the lipodots; (C2–C5) Magnified images of the lipodots of similar magnification.
Abbreviation: TeM, transmission electron microscope.
from dynamic quenching by molecular oxygen. Opposite 
to what is expected in the presence of oxygen (decrease of 
lifetime due to energy transfer from QDs to nearby oxygen 
molecules), Anas et al actually reported fluorescence increase 
in the presence of oxygen.52 Furthermore, photo-enhance-
ment of QD fluorescence was observed both in air and in 
nitrogen saturated cells53 and solutions.54 This presumably 
can be attributed to residual oxygen adsorbed on the QD 
surface54 and the oxygen passivation effect.55 Passivation 
is the process of making a material passive in relation to 
another material. In case of QDs, different materials (eg, 
trioctylphosphine [TOP] and its oxide, trioctylphosphine 
oxide [TOPO]; amines; mercapto-terminated molecules; 
and carboxyls) are used as surface ligands (known as pas-
sivating ligands) to prevent agglomeration of QDs during 
synthesis, protect their surfaces, and make them soluble in International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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various solvents.56 Capping with a shell such as a ZnS-shell 
layer can also passivate surface defects.57 Surface states not 
blocked by capping ligands may form surface defects such 
as Cd and/or Se dangling bonds, introducing energy trap 
states that are involved in nonradiative recombination. Type 
and quality of surface passivating ligands are important for 
the optical and electrochemical properties of QDs.58 Surface 
passivation by oxygen (chemical or physical adsorption) 
eliminates such defects, causing an increase in radiative 
recombination.59 However, a series of redox processes medi-
ates further surface oxidation in air60 or under UV exposure45 
leading to SeO2, CdO, CdSeO3, and CdSeO4 formation and 
particle size reduction.
Endosomal entrapment is one of the problems QDs 
encounter upon entry into a cell. This could be the reason for 
the lack of significant photoeffect on cell killing by QDs.36 For 
an efficient photosensitization, QDs must reach and interact 
with vital parts of the cell, and the first barrier to this action is 
their persistence in endosomes and lysosomes. This study was 
further focused on investigating photophysical changes of QDs 
encapsulated in lipid vesicles in comparison to intact QDs with 
the goal to understand how to overcome quenching of both 
fluorescence and phototoxicity of QDs. Artificial phospholipid 
nanoparticles (liposomes) may serve as a simplified model 
to investigate the effects of endosomal/lysosomal vesicles 
on the photophysical properties of QDs in a cell. Indeed, red 
fluorescence of QDs is quenched (  Figure 6A) and its lifetime 
decreases (Figure 6B) upon their encapsulation in phospholipid 
vesicles, while the presence of surfactant or empty liposomes 
has no or little effect on the lifetime, respectively. It has already 
been shown that irradiation with blue light increases the fluo-
rescence of endocytosed QDs in cells53 and presumably leads to 
rupture of lysosomes.40 Our liposomal model confirms this by 
showing an increase in fluorescence intensity after irradiation 
(Figure 6A). The fluorescence lifetime of QDs also increased 
after   irradiation with blue or red light, which was irreversible, 
as after 24 hours the lifetime remained unchanged (Figure 7). 
  Interestingly, mixing QDs with empty liposomes also resulted 
in a decreased fluorescence lifetime showing self-assembly of 
QDs with lipid vesicles (Figure 8). Just as for the lipodots, the 
irradiation caused an increase in fluorescence lifetime of such 
QD-phospholipid assemblies (Figure 8). However, differently 
from the liposomes that irreversibly leaked (Figure 8, curve 
2 vs curves 4 and 5 for lipodots), after irradiation the QDs 
reassembled with the empty liposomes, resulting again in 
decreased fluorescence lifetime (Figure 8, curve 3 vs curves 
4 and 5 for QD655).
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It must be noted that nonspecific passive delivery of QDs, 
though noninvasive and supposedly not compromising cell 
integrity and viability, completely relies on endocytosis.61,62 
However, similar QDs from clathrin-coated pits can be des-
tined for different fates after internalization: sent back to the 
cell surface, trafficked toward a degradative fate in endosomes 
and lysosomes, or to the perinuclear recycling endosomal 
compartment, depending on cell phenotype.63 This means 
that internalization and trafficking of QDs, though highly 
controlled by the cell, can be manipulated by choosing proper 
targeting ligands. To increase passive intracellular loading, 
QDs may be coupled with ligands targeting surface mem-
brane receptors such as growth factors or folate.64,65 Active 
techniques like electroporation and microinjection66,67 can 
deliver these nanocrystals directly into the cytosol, but such 
delivery is invasive and was outside the scope of this paper. 
Quantum dots bioconjugated to different ligands, which are 
normally transported from endosomes to the Golgi apparatus, 
have also been found arrested in endosomes without routing 
them to Golgi.68 Thus, such endosomal-lysosomal entrapment 
of bare or bioconjugated QDs may affect cell physiology as 
well as the imaging/therapeutic potential, preventing QDs 
from finding intracellular targets.17   Peptide-coated QDs are 
a novel strategy to enhance QD delivery in mammalian cells. 
Cationic arginine-type peptide has been shown to increase 
endocytosis with subsequent transport of QDs to lysosomes.69 
Bioconjugation of QDs with cell-penetrating polyarginine-
type peptide has resulted in partial colocalization of the 
QDs within endosomes.70 Furthermore, coating with hyper-
branched copolymer ligands has demonstrated an endosome-
disrupting effect (endosomolysis).71 The osmotic-imbalance 
strategy can also be employed by dipeptides that are cleaved by 
lysosomal dipeptidase.72 Approaches like endosomal escape, 
non-endocytic uptake routes, and endosomal disruption may 
facilitate targeting of intracellular organelles by QDs.66
One possible approach to overcome this endocytic control 
system for specific QD delivery inside the cell and additional 
specificity for QD delivery in vivo is loading of QDs into 
lipid-based polymers.66 Hydrophobic QDs can be entrapped 
into phospholipid micelles or in a lipid bilayer of liposomes, 
while hydrophilic QDs will localize in the central aqueous 
compartment of such liposomes. There are significant find-
ings in liposome-mediated drug delivery for photodynamic 
therapy, and at least one liposome-based commercial pho-
tosensitizer is available for clinical application already,73 
making liposomes of particular interest for specific QD 
delivery. Schroeder et al recently developed lipodots74 with 
QDs entrapped in a lipid shell for effective folate receptor 
targeted delivery of QDs. Liposomal QDs show improved 
shelf life stability and intracellular delivery.75,76
We have further checked the possibility of intracellular 
proteins to exert an effect on QD fluorescence. Indeed, in a 
model solution after incubation at room temperature with 
BSA, QD fluorescence lifetime decreased (Figure 9, curve 2 
vs 3) and after ∼100 h, the fluorescence was completely 
quenched (Figure 10). Such fluorescence decrease is due to 
static quenching through Förster Resonance Energy Transfer 
(FRET). The PEG layer of the QDs serves as a capping agent 
providing steric hindrance. The protein molecule needs time 
to reach the inorganic part of the QDs. Increasing temperature 
lowers the PEG density and facilitates the protein adhesion to 
the QD surface. Ipe and Niemeyer observed a decrease of QD 
fluorescence in the presence of cytochrome.33 Interestingly, 
the authors detected triggering of the enzyme activity suppos-
edly due to its photoactivation by QDs. Furthermore, just like 
0.0
02 04 0
Time (ns)
F
l
u
o
r
e
s
c
e
n
c
e
 
(
r
e
l
.
 
u
n
i
t
s
)
60 80
600 620 640
Wavelength (nm)
660
Lipodots (irradiated)
QD655
Lipodots
680 700
0.5
1.0
10
F
l
u
o
r
e
s
c
e
n
c
e
 
(
r
e
l
.
 
u
n
i
t
s
)
100
1000
IRF (1)
Water (2)
PBS (3)
Triton (4)
Liposomes (5)
Lipodots (6)
A
B
Figure 6 (A) Fluorescence spectra of QD655 in PBs and lipodots. (B) Fluorescence 
decay of QD655 in different solutions. Fluorescence intensity is normalized to 1 at 
initial values.
Abbreviations: QD, quantum dot; PBs, phosphate buffered saline.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1883
Free radical generation by lipodots
photo-enhancement of QD fluorescence in cells or lipodots, 
we demonstrated photo-enhancement of QD fluorescence in 
aqueous solutions with BSA (Figure 11). Immediately after 
irradiation, the fluorescence lifetime increased, and the decay 
curve was comparable to the initial one (Figure 9, curve 2 
vs 4). However, additional storage after irradiation caused 
readhesion of BSA to QDs and decrease in fluorescence life-
time (Figure 9, curve 4 vs 5). Lifetimes of QD fluorescence 
in different environments are summarized in Table 1.
It is well known that different cell organelles have dif-
ferent acidities77 to sustain certain pH-sensitive enzyme 
profiles.78 Although the mechanisms by which intracellular 
vesicle trafficking regulated by an acidic pH remain unclear, 
the approximate intravesicular pH values are established to 
be around 5.5–6.5 for the endosomes, lysosomes, and trans-
Golgi network and 7.2 for the endoplasmic reticulum and 
cytosol.78 In formaldehyde-fixed cells, it has been noticed that 
QDs lost their fluorescence when the cells were immersed 
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Table 1 Fluorescence lifetimes of QD655 in different solutions and the fluorescence lifetimes of lipodots before and after irradiation 
with the blue light
QD655 in τ1, ns a1 τ2, ns a2
0 hours PBs 15.2*, ±0.2 1 –, – –
PBs with BsA 16.5, ±0.2 1 –, – –
Liposome solution 15.0, ±0.1 1 –, – –
20 hours PBs 14.2, ±0.2 1 –, – –
PBs with BsA 10.6*, ±0.5 0.75* 27*, ±3 0.25*
Liposome solution 8.8, ±0.6 0.73 21, ±3 0.27
20 hours + irradiation PBs, 3 hours irradiation 16.7, ±0.1 1 –, – –
PBs with BsA, 3 hours irradiation 15.8*, ±0.2 1 –, – –
Liposome solution, 30 minutes irradiation 12.0, ±0.5 0.78 48, ±5 0.22
20 hours after irradiation PBs 15.4, ±0.1 1 –, – –
PBs with BsA 11.4, ±0.1 1 –, – –
Liposome solution 12.0, ±0.1 1 –, – –
Lipodots
Kept in darkness 7.6, ±0.2 1 –, – –
Irradiated 15 minutes 9.4, ±0.2 1 –, – –
Irradiated 30 minutes 9.8, ±0.2 1 –, – –
24 hours after irradiation 9.0, ±0.2 1 –, – –
24 hours after irradiation, irradiated 15 minutes 9.9, ±0.1 1 –, – –
Notes: τ 1,2, fluorescence lifetime (first and second exponent); a1,2, pre-exponential factor (less than 1 in case of two exponential decay); *Presumptive values due to 
unsatisfactory statistics (χ2 = 0.5/1.5 and DW $ 1.5); Mathematical calculations were performed with easyLife V software (OBB corp, Birmingham, NJ). The presented 
values are taken from fitted curves with the most satisfactory statistical parameters: χ2 = 0.8/1.2 and Durbin–Watson (DW) $ 1.7. The errors were calculated by software 
automatically. The error for pre-exponential factors is ±0.01.
Abbreviations: BsA, bovine serum albumin; PBs, phosphate buffered saline.
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in a buffer of pH 4.6.79 In the present study, we have thus 
investigated whether fluorescence quenching in living cells 
could be explained by the acidic environment in endosomes 
and lysosomes. Clearly, the QD fluorescence profile is pH 
dependent (Figure 12) with maximal photoluminescence 
intensity at pH 7 (corresponding to that of cytosol) and only 
20%–30% of the initial intensity at pH 5 (equivalent to that 
of lysosomes). Acidic aqueous solution contains protons in 
abundance, which can etch the ZnS layer of the QDs, thus 
impairing surface passivation effect and decreasing radiative International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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recombination. Since the photoluminescence intensity was 
not completely quenched at pH 5–6, loss of QD fluorescence 
in living cells cannot be explained solely by the low pH of 
these organelles. Upon entrapment in vesicles, the effect 
of self-quenching by high local fluorophore concentrations 
could be another possible factor.80
Conclusions
The present study using an in vitro liposomal model has 
demonstrated that QDs lose their fluorescence and photosen-
sitizing action when entrapped in phospholipid vesicles. In 
addition, acidic environment (pH , 6) and protein adsorption 
also leads to quenching of QD fluorescence. Our model mim-
ics the effect of the QD fluorescence quenching and reappear-
ance as it happens in endocytic vesicles of living cells. Design 
of QDs that can either escape endosomes or lysosomes, or 
are routed through other internalization pathways to avoid 
entrapment in endocytic vesicles, is desirable to make them 
suitable for photodynamic applications.
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